Evidence map›Paper›PMID 32102367›Full record

ReviewPathogens (Basel, Switzerland)2020

Evaluation of Disease Causality of Rare

Tal Azagi, Dieuwertje Hoornstra, Kristin Kremer, Joppe W R Hovius, Hein Sprong

Abstract readReview
In one paragraph

Review in Pathogens (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Exploration of geographical population structure ofCurrent research in parasitology & vector-borne diseases · 2026
    Article
  5. Article
  6. Deep sequencing of 16mSystems · 2025
    Article
  7. Molecular Surveillance ofPathogens (Basel, Switzerland) · 2025
    Article
  8. Article
  9. Article
  10. Pathogens (Basel, Switzerland) · 2025
    Article
  11. European human granulocytic anaplasmosis is caused by a subcluster ofCurrent research in parasitology & vector-borne diseases · 2025
    Article
  12. Current research in parasitology & vector-borne diseases · 2025
    Article
  13. Prevalence ofInsects · 2024
    Article
  14. Article
  15. Multi-epitope Based Peptide Vaccine Candidate AgainstBioinformatics and biology insights · 2024
    Article
  16. Spatial and temporal variation of five different pathogens and symbionts inCurrent research in parasitology & vector-borne diseases · 2024
    Article
  17. Development of a Model for Preliminary Diagnosis of Human Granulocytic Anaplasmosis.Vector borne and zoonotic diseases (Larchmont, N.Y.) · 2023
    Article
  18. Article
  19. A Forty-Year Analysis of the Literature onInternational journal of environmental research and public health · 2023
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tal AzagiCentre for Infectious Diseases Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Dieuwertje HoornstraCenter for Experimental and Molecular Medicine, Amsterdam University Medical Centers Location Academic Medical Center, Amsterdam, The Netherlands.
Kristin KremerCentre for Infectious Diseases Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.
Joppe W R HoviusCenter for Experimental and Molecular Medicine, Amsterdam University Medical Centers Location Academic Medical Center, Amsterdam, The Netherlands.
Hein SprongCentre for Infectious Diseases Research, National Institute for Public Health and the Environment, Bilthoven, The Netherlands.

Funding

European Interreg North Sea Region program NorthTickZonMW 50-52200-98-313
6 · The paper itself

Abstract

In Europe,

Indexed as

BabesiosisBorrelia miyamotoi DiseaseHuman Granulocytic AnaplasmosisIxodes ricinusNeoehrlichiosisSpotted Fever Rickettsiosistick-borne diseases

Identifiers

PMID32102367
PMCPMC7168666

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.